izokibep
acelyrin
[' psa', 'izokibep']
#abst0199 #acr22 phase ii study: izokibep -highly potent il-17a inhibitor w/small molecular size designed to overcome limitations of monoclonal abs: dose-dependent improvement in sf36 &amp; psaid subdomains, notable improvements in sleep, pain&amp; function. best in enthesitis 
Rheumatologist at Scarsdale Medical Group, Runner, Traveler Opinions are my own